StonvexLoading…
StonvexStonvexStonvexCore line items from GENC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $115.44M | $113.17M | $105.08M | $103.48M |
Operating Income | $14.02M | $13.69M | $13.43M | $4.17M |
Net Income | $15.66M | $14.56M | $14.67M | $-372.00K |
EPS (Diluted) | $1.07 | $0.99 | $1.00 | $-0.03 |
Total Assets | $222.60M | $208.12M | $195.92M | $179.31M |
Total Liabilities | $10.79M | $11.98M | $14.34M | $12.40M |
Cash & Equivalents | $26.59M | $25.48M | $17.03M | $9.58M |
Free Cash Flow OCF − CapEx | $1.10M | $8.45M | $7.45M | $-13.65M |
Shares Outstanding | Not available | Not available | 14.66M | 14.66M |